纯自主神经衰竭向突触核蛋白病转化预测
该回顾性研究纳入2001至2011年Mayo Clinic Rochester的275例纯自主神经衰竭患者,随访评估向多系统萎缩、帕金森病或痴呆伴路易小体的转化。67例(24%)发生转化,其中34例为多系统萎缩,33例为帕金森病或痴呆伴路易小体;起病年龄、膀胱症状、细微运动体征、仰卧位去甲肾上腺素水平、出汗模式及梦演绎行为等基线特征与转化风险相关。
要点
- 约四分之一纯自主神经衰竭患者转化为多系统萎缩、帕金森病或痴呆伴路易小体。
- 细微运动体征、严重膀胱症状和梦演绎行为提示转化风险增加。
- 多系统萎缩转化者起病年龄更轻,仰卧位去甲肾上腺素水平更高及节前性无汗模式更常见。
核心结论
- 至少四分之一的纯自主神经衰竭患者会转化为多系统萎缩、帕金森病或痴呆伴路易小体。
- 基线特征可区分向多系统萎缩转化与向帕金森病或痴呆伴路易小体转化的不同模式。
研究设计与样本
- 回顾性研究,纳入2001至2011年Mayo Clinic Rochester的275例纯自主神经衰竭患者,通过临床随访和电话评估转化。
主要发现
- 275例中67例(24%)转化为突触核蛋白病,其中34例符合多系统萎缩标准,33例符合帕金森病或痴呆伴路易小体标准。
- 多系统萎缩转化者起病年龄更轻,严重膀胱症状更常见,仰卧位去甲肾上腺素水平更高及节前性无汗模式更常见。
- 细微运动体征在多系统萎缩和帕金森病或痴呆伴路易小体转化者中均更频繁。
- 预测多系统萎缩转化的基线变量包括细微运动体征、仰卧位去甲肾上腺素水平、严重膀胱症状和梦演绎行为。
- 预测帕金森病或痴呆伴路易小体转化的基线变量包括细微运动体征、梦演绎行为和便秘。
关键数值与推荐
- 该研究提供II级证据:细微运动体征、严重膀胱症状和梦演绎行为与转化为伴运动或认知受累的突触核蛋白病风险增加相关。
临床怎么用
- 对纯自主神经衰竭患者,应评估细微运动体征、膀胱症状、梦演绎行为、便秘及仰卧位去甲肾上腺素水平等基线特征以分层转化风险。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To determine predicting factors and frequency of phenoconversion from pure autonomic failure (PAF) into a synucleinopathy with motor or cognitive involvement of multiple system atrophy (MSA), Parkinson disease (PD), or dementia with Lewy bodies (DLB). METHODS: We performed a retrospective review of all patients with PAF from 2001 to 2011 evaluated at Mayo Clinic, Rochester. Clinical follow-up and patient telephone calls were used to assess for development of symptoms and diagnosis of MSA, PD, or DLB. Clinical and laboratory variables were extracted with factors predictive of evolution assessed using group comparison, odds ratio, and logistical regression. RESULTS: Among 275 patients with PAF at presentation, 67 (24%) phenoconverted to a synucleinopathy with motor or cognitive involvement; 34 met criteria for MSA, while 33 met criteria for PD or DLB. Age at onset was younger in MSA phenoconverters. Clinical features at presentation influenced phenoconversion: severe bladder symptoms were more common in MSA phenoconverters; subtle motor signs were more frequent in MSA and PD/DLB phenoconverters. MSA phenoconverters were more likely to have higher supine norepinephrine levels and preganglionic pattern of anhidrosis. Presentation variables predicting MSA phenoconversion included subtle motor signs, supine norepinephrine levels, severe bladder symptoms, and dream enactment behavior. Presentation variables predictive of PD/DLB phenoconversion included subtle motor signs, dream enactment behavior, and constipation. CONCLUSIONS: Our findings suggest that at least a quarter of patients with PAF phenoconvert to MSA, PD, or DLB. Presentation features determine patients at risk for evolution with specific patterns indicative of phenoconversion to MSA vs PD/DLB. CLASSIFICATION OF EVIDENCE: This study provides Class II evidence that several presentation variables including subtle motor signs, severe bladder symptoms, and dream enactment behavior are associated with an increased risk of developing a synucleinopathy with motor or cognitive involvement.
引用
- Coon EA, Mandrekar JN, Berini SE, et al. Predicting phenoconversion in pure autonomic failure. Neurology. 2020. PMID: 32546656. doi:10.1212/WNL.0000000000010002
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。